4//SEC Filing
Rajavelu Esther 4
Accession 0000950170-24-125339
CIK 0001701108other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:05 PM ET
Size
6.3 KB
Accession
0000950170-24-125339
Insider Transaction Report
Form 4
Rajavelu Esther
CFO & CBO
Transactions
- Sale
Common Stock
2024-11-08$1.30/sh−17,245$22,419→ 379,270 total - Sale
Common Stock
2024-11-07$1.31/sh−23,351$30,590→ 396,515 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on November 13, 2023.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001903716
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:05 PM ET
- Size
- 6.3 KB